For years, the name “polycystic ovary syndrome” directed attention toward cysts, ovaries and reproduction. On 12 May 2026, an international initiative adopted a new name: polyendocrine metabolic ovarian syndrome (PMOS).
The change is not a cure, and it does not erase the experiences of millions of people living with the condition. It does, however, describe the condition more honestly. PMOS can affect reproductive, hormonal, metabolic and psychological health across a person's life—not only when they want to become pregnant.
Medical note: This page provides general information. Symptoms and treatment differ from person to person. Speak with a qualified healthcare professional for diagnosis, screening and a care plan suited to you.
What does the change from PCOS to PMOS mean?
The old name created two common misunderstandings. First, it suggested that ovarian cysts were the defining feature, even though a person can meet diagnostic criteria without polycystic ovaries. Second, it encouraged patients and even some clinicians to focus on irregular periods and fertility while giving less attention to metabolic risk.
The new words—polyendocrine and metabolic—bring the broader picture into the name itself. The international process was led by researchers and clinicians working with people who have lived experience of the condition and professional organisations across many countries.
This matters because language affects what questions get asked. A patient hearing “ovary syndrome” may reasonably assume the condition can be ignored unless she wants a child. A patient hearing “endocrine and metabolic” is more likely to ask about glucose, blood pressure, cholesterol, sleep, mental health and long-term monitoring.
The new name moves the patient into view as a whole person—not only as somebody who may want to become pregnant.
A condition that can affect the whole body
The World Health Organization estimates that PMOS affects roughly 10% to 13% of women of reproductive age, and that up to 70% of affected women worldwide may not know they have it. Symptoms vary and may change over time.
Possible signs include irregular or absent periods, difficulty with ovulation, acne, oily skin, excess facial or body hair, or thinning hair on the scalp. Not everyone has every sign. The condition may also be associated with insulin resistance, type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea and increased cardiovascular risk.
Emotional health belongs in the same conversation. Anxiety, depression, eating difficulties, body-image distress and weight stigma can have a substantial impact on quality of life. These experiences should not be treated as cosmetic side notes.
One composite patient was diagnosed after going five months without a period at 18. She remembered being told that nothing needed attention until she wanted children. Almost a decade later, during pre-pregnancy screening, she was diagnosed with type 2 diabetes and learned that insulin resistance was part of the health picture her earlier conversations had missed.
One story cannot establish cause, and not everyone with PMOS will develop diabetes. But her anger points to a wider failure: fertility-centred care can delay conversations about health that matters now.

How medical names shape attention
A disease name is never only a label. It influences which specialist a patient visits, what a clinician remembers to screen, what search results appear and what families believe the condition means.
Debate over the old PCOS name had continued for decades. The 2026 decision followed an international consensus process rather than a casual rebrand. The updated term aims to improve recognition while preserving continuity: during the transition, patients will still encounter “PCOS” in medical records, older research and public information.
That transition needs care. A new acronym can initially create confusion or make reliable older information harder to find. For that reason, this page uses both terms. PMOS is the current name; PCOS remains an important search and historical term.
When language creates fear or shame
The problem is larger than one condition. Women's health has often been described with language that implies damage, dirtiness or moral failure.
For example, cervical ectropion is a common situation in which glandular cells from inside the cervical canal are visible on the outer cervix. Older language in some countries described the appearance as an “erosion,” a word that can sound like decay. In many people it causes no problem and needs no treatment, although symptoms such as bleeding or unusual discharge should still be assessed so other causes can be excluded.
Postpartum lochia is another ordinary biological process that can be poorly understood. It is the vaginal discharge of blood, mucus and uterine tissue that occurs while the uterus recovers after birth. A neutral explanation helps people understand what is expected and when a change warrants medical attention.
Terms for anatomy can carry cultural baggage too. The hymen is not a sealed freshness marker, and its appearance cannot establish whether someone has had sex. Bodies do not supply moral evidence.
Stigma has practical consequences. It can keep people out of consulting rooms or make them vulnerable to unnecessary, expensive procedures marketed through fear. Accurate language cannot solve every healthcare failure, but it can remove one barrier between a person and appropriate care.
What should someone with possible PMOS do?
If you have irregular periods, signs of higher androgen levels or concerns about ovulation, ask a qualified clinician whether PMOS should be considered and what other explanations need to be ruled out. Diagnosis uses a combination of history, symptoms and tests; ovarian cysts are not required in every case.
After diagnosis, ask what metabolic and cardiovascular checks are appropriate for you. Depending on your history, that conversation may include glucose testing, blood pressure, cholesterol, sleep and emotional wellbeing. Treatment should be individualised and based on shared decision-making.
Healthy eating, movement and sleep can support health, but care should not collapse into blame about weight. Medication, cycle management, skin or hair treatment, mental-health support and fertility care may all be relevant at different times. There is no single plan that fits everyone.
Most importantly, you do not need to wait until you want a child to ask for care. Your present health is reason enough.
Editorial note: A reproductive-health diagnosis should never reduce someone to future fertility. Ask what the condition means for your health now, which long-term checks apply to you and how treatment decisions can reflect your own priorities.
Editorial method, sources and review
How this article was prepared
The editorial team compared the terminology, prevalence and care statements with the WHO fact sheet, the published international consensus and the updated Monash guideline. The patient vignette is a composite editorial scenario, not an identifiable person's testimony.
Professional-source review completed 2 September 2026. No individual clinician has reviewed this article; it is general education, not diagnosis or treatment advice.
Sources
- World Health Organization: Polycystic ovary syndrome fact sheetPrevalence, symptoms, diagnosis and long-term health context.
- The Lancet consensus: transition from PCOS to PMOSPrimary consensus publication for the 2026 terminology change.
- Monash University: updated PMOS guidelineClinical guidance supporting whole-person assessment and care.
See our editorial standards. To report a factual or safety concern, use the official support route and include this page URL.